News
Santo Domingo.- Health authorities in the Dominican Republic have issued a warning about potential adverse reactions linked ...
Colgate-Palmolive's growth is lackluster, with long-term sales and earnings barely keeping pace with inflation. Learn why CL ...
Colgate-Palmolive Company (NYSE:CL) is included among the 10 Best Passive Income Stocks to Buy Now. The company has been ...
Haleon plc had a decent quarter, mostly driven by price. Click here to read more about HLNCF stock and why it is a Hold.
PG, CL, CHD, and GO push through margin pressures with innovation, cost control, and digital growth amid tough consumer ...
StockStory.org on MSN13d
Colgate-Palmolive (CL): Buy, Sell, or Hold Post Q1 Earnings?Colgate-Palmolive trades at $92.78 per share and has stayed right on track with the overall market, gaining 6% over the last ...
Detailed price information for Colgate-Palmolive Company (CL-N) from The Globe and Mail including charting and trades.
The global Oral Care Market, valued at US$34.97 billion in 2024 stood at US$37.21 billion in 2025 and is projected to advance ...
Colgate-Palmolive's forward PE ratio is 22.48 compared to Procter & Gamble's 18.84 and Unilever's 19.30, indicating that Colgate-Palmolive is over-priced relative to its peers.
Colgate-Palmolive’s (NYSE: CL) stock has gone from $67.42 in November 2016 to $66.52 in November 2019. Over this period there has been a ~3% rise in total revenue and an equal drop in number of ...
Colgate-Palmolive’s chief executive recently signaled he would be open to selling the company — which has grappled with sluggish demand for its toothpaste, deodorants and food products — for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results